Penumbra (PEN) Enterprise Value (2014 - 2026)
Penumbra (PEN) posted quarterly Enterprise Value of -$658.8 million for Q2 2026, down 55.17% year-over-year from -$1.5 billion in Q2 2025, and down 7.01% quarter-over-quarter from -$615.7 million in Q1 2026.
Penumbra (PEN) Enterprise Value (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Enterprise Value for 13 consecutive years, with -$658.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value fell 55.17% year-over-year to -$658.8 million; the TTM figure through Jun 2026 stood at -$658.8 million (down 55.17% YoY), while the FY2025 annual figure was -$544.8 million, down 60.18% from the prior year.
- Enterprise Value declined to -$658.8 million in Q2 2026 per PEN's latest filing, from -$615.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$184.4 million in Q3 2022 and bottomed at -$658.8 million in Q2 2026.
- Historically, Enterprise Value has averaged -$341.8 million across 5 years, with a median of -$302.2 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 32.48% — and 2026, when it slumped 62.51%.
- Penumbra's Enterprise Value stood at -$188.0 million in 2022, then tumbled by 53.8% to -$289.2 million in 2023, then retreated by 17.62% to -$340.1 million in 2024, then slumped by 60.18% to -$544.8 million in 2025, then declined by 20.92% to -$658.8 million in 2026.
- Business Quant data shows PEN's Enterprise Value at -$658.8 million in Q2 2026, -$615.7 million in Q1 2026, and -$544.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | -658.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -658.80 Mn |
| Mar 31, 2026 | -615.66 Mn |
| Dec 31, 2025 | -544.82 Mn |
| Sep 30, 2025 | -470.30 Mn |
| Jun 30, 2025 | -424.56 Mn |
| Mar 31, 2025 | -378.85 Mn |
| Dec 31, 2024 | -340.13 Mn |
| Sep 30, 2024 | -291.02 Mn |
| Jun 30, 2024 | -339.70 Mn |
| Mar 31, 2024 | -313.47 Mn |
| Dec 31, 2023 | -289.19 Mn |
| Sep 30, 2023 | -248.86 Mn |
| Jun 30, 2023 | -221.06 Mn |
| Mar 31, 2023 | -199.10 Mn |
| Dec 31, 2022 | -188.03 Mn |
| Sep 30, 2022 | -184.43 Mn |
| Jun 30, 2022 | -204.37 Mn |
| Mar 31, 2022 | -240.34 Mn |
| Dec 31, 2021 | -254.88 Mn |
| Sep 30, 2021 | -273.13 Mn |